搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Coxiella burnetii 30S ribosomal protein S7 (rpsG) CSB-YP431922DXO
CSB-EP431922DXO
CSB-BP431922DXO
CSB-MP431922DXO
CSB-EP431922DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase (metE), partial CSB-YP431923DXO
CSB-EP431923DXO
CSB-BP431923DXO
CSB-MP431923DXO
CSB-EP431923DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Phosphoenolpyruvate carboxykinase [ATP] (pckA), partial CSB-YP431924DXO
CSB-EP431924DXO
CSB-BP431924DXO
CSB-MP431924DXO
CSB-EP431924DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Enolase (eno) CSB-YP431925DXO
CSB-EP431925DXO
CSB-BP431925DXO
CSB-MP431925DXO
CSB-EP431925DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii 50S ribosomal protein L32 (rpmF) CSB-YP431926DXO
CSB-EP431926DXO
CSB-BP431926DXO
CSB-MP431926DXO
CSB-EP431926DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Ribosome maturation factor RimM (rimM) CSB-YP431927DXO
CSB-EP431927DXO
CSB-BP431927DXO
CSB-MP431927DXO
CSB-EP431927DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Lipoprotein signal peptidase (lspA), partial CSB-YP431928DXO1
CSB-EP431928DXO1
CSB-BP431928DXO1
CSB-MP431928DXO1
CSB-EP431928DXO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY), partial CSB-YP431929DXO
CSB-EP431929DXO
CSB-BP431929DXO
CSB-MP431929DXO
CSB-EP431929DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Outer-membrane lipoprotein lolB (lolB) CSB-YP431930DXO
CSB-EP431930DXO
CSB-BP431930DXO
CSB-MP431930DXO
CSB-EP431930DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP431931DXO
CSB-EP431931DXO
CSB-BP431931DXO
CSB-MP431931DXO
CSB-EP431931DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (gpmI), partial CSB-YP431932DXO
CSB-EP431932DXO
CSB-BP431932DXO
CSB-MP431932DXO
CSB-EP431932DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Pyridoxine 5'-phosphate synthase (pdxJ) CSB-YP431933DXO
CSB-EP431933DXO
CSB-BP431933DXO
CSB-MP431933DXO
CSB-EP431933DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Tetraacyldisaccharide 4'-kinase (lpxK) CSB-YP431934DXO
CSB-EP431934DXO
CSB-BP431934DXO
CSB-MP431934DXO
CSB-EP431934DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Dihydrodipicolinate synthase (dapA) CSB-YP431935DXO
CSB-EP431935DXO
CSB-BP431935DXO
CSB-MP431935DXO
CSB-EP431935DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Ribosomal RNA large subunit methyltransferase N (rlmN) CSB-YP431936DXO
CSB-EP431936DXO
CSB-BP431936DXO
CSB-MP431936DXO
CSB-EP431936DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii DNA mismatch repair protein MutS (mutS), partial CSB-YP431937DXO
CSB-EP431937DXO
CSB-BP431937DXO
CSB-MP431937DXO
CSB-EP431937DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP431938DXO
CSB-EP431938DXO
CSB-BP431938DXO
CSB-MP431938DXO
CSB-EP431938DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Phosphoglucosamine mutase (glmM) CSB-YP431939DXO
CSB-EP431939DXO
CSB-BP431939DXO
CSB-MP431939DXO
CSB-EP431939DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coxiella burnetii Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP431940DXO
CSB-EP431940DXO
CSB-BP431940DXO
CSB-MP431940DXO
CSB-EP431940DXO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium phytofermentans N-acetyl-gamma-glutamyl-phosphate reductase (argC) CSB-YP431941CWZ
CSB-EP431941CWZ
CSB-BP431941CWZ
CSB-MP431941CWZ
CSB-EP431941CWZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>